Phosphonamidate Compounds for Butyrylcholinesterase Selective Inhibitors | Zendy

Oh Jintaek | Zendy; Park JungYoul | Zendy; Park Kyoung Chan | Zendy; Hwang Ji Hyun | Zendy; Park Jeong Ho | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Phosphonamidate Compounds for Butyrylcholinesterase Selective Inhibitors

Author(s) -

Oh Jintaek,

Park JungYoul,

Park Kyoung Chan,

Hwang Ji Hyun,

Park Jeong Ho

Publication year - 2020

Publication title -

bulletin of the korean chemical society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.237

H-Index - 59

ISSN - 1229-5949

DOI - 10.1002/bkcs.12126

Subject(s) - butyrylcholinesterase , acetylcholinesterase , aché , cholinesterase , galantamine , chemistry , cholinergic , stereochemistry , enzyme , combinatorial chemistry , organic chemistry , pharmacology , medicine , donepezil , dementia , disease

To find a new type of cholinergic drug, phosphonamidate compounds 18–32 were synthesized using a click reaction between propargylated‐9,10‐Dihydro‐9‐oxa‐10‐phosphaphenanthrene‐10‐oxide (DOPO, 2 ) and substituted benzyl azide. Their inhibitory activity against butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE) was evaluated. Compound 31 was the most active of the 15 compounds (IC 50 = 3.14 ± 0.02 μM for equine BuChE), whose IC 50 value was slightly lower than the IC 50 value of galantamine (IC 50 = 9.4 ± 2.50 for equine BuChE).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research